Larson Electronics Magnalight has unveiled its EPL-RPS-1MLED explosion-proof LED light. It is cart-mounted for easy mobility and can shine light up to 5,000 feet.
Kwalu introduced seven new products in April, including the Avella Lift chair.
Mobile health provider SecuraTrac announced new technology based off of its SecuraFone®. Developed with Vital Connect, SecuraFone Health can tell physicians, caregivers and family in real-time when an unexpected health event occurs
Denise Wassenaar, RN, MS, NHA, has joined MDI Achieve as the new chief clinical officer, the company announced.
The Mayo Clinic has received a patent for a new medication selection procedure. GeneSight uses a test to prioritize the selection of medications for patients with depression, chronic pain and other psychiatric disorders.
Matthew D. Eyles has joined Avalere Health as executive vice president. He arrives from Coventry Healthcare.
Medical manufacturer and distributer HARTMANN USA has announced an expansion in Rock Hill, SC, that involves moving its incontinence management production site.
The Food and Drug Administration expanded an alert about NuVision Pharmacy of Dallas, TX, on Saturday. It said investigators found poor sterile production practices that raised concern about a lack of sterility assurance for the company's sterile drug products.
Healthland, an electronic health records vendor primarily focused on the rural hospital market, has acquired American HealthTech.
CFG Capital Markets, the investment banking platform of Capital Funding Group, announced it was an advisor on a $141.7 million portfolio.
Pfizer must pay $142 million for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a federal appeals court has ruled. The justices refused to overturn a jury's previous verdict. The jury determined Pfizer marketed Neurontin for bipolar disorder, migraines and neuropathic pain. The Food and Drug Administration had not approved the medicine for any of those uses.
The approval of Biogen Idec's MS therapy Tecfidera follows months of breathless Wall Street hype, and it looks like doctors are psyched for the drug, too. In a MedLIVE PULSE survey conducted by WorldOne Interactive, 40% of U.S neurologists polled said they're currently warehousing patients in anticipation of the new multiple sclerosis drug.
The estate of a woman who died in an Emeritus Corp. senior living community may pursue wrongful death and medical malpractice claims without providing expert testimony, U.S. District Court Judge Dan Aaron Polster has ruled.